49 Pharma Startups in UK to Watch in 2024
How do we build this list?
Tracking:
Last update to the database: April 9, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Biomedical research discovery tool. |
$60M · Series B | ICONIQ Growth, Index Ventures, Pentech Ventures | 51 to 100 | Health Tech, AI, Biotech, Pharma | B2B, SaaS | London, UK | •••••••••••@causaly.com | |
Portfolio of pharmaceutical research and discovery. |
$33M · Series C | Patient Square Capital, Rock Springs Capital, M&G Investments | 1 to 10 | Biotech, Pharma | London, UK | •••••••••••@apollotherapeutics.com | ||
Cancer treatment predictor software. |
$14M · Series A | Hoxton Ventures, Octopus Ventures, Fly Ventures | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@pearbio.com | |
Patent-protected anti-inflammatory painkiller. |
$6M · Series A | ITV AdVentures | 1 to 10 | Biotech, Pharma | B2C | London, UK | •••••••••••@flarin.co.uk | |
ReViral is a biotechnology company that develops and offers antiviral therapies for patients. |
$44M · Series C | Novo A/S, Andera Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@reviral.co.uk | |
Manual provides diagnostic tools and testing to help patients make health-related decisions. |
$6M · Seed | Felix Capital, Cherry Ventures, FJ Labs | 11 to 50 | Health Tech, Fashion, Pharma, Mobile, Ecommerce | B2C | London, UK | •••••••••••@manual.co | |
The Charac app streamlines access to your local pharmacy. Skip the queue, save time and access all of your prescriptions from anywhere. |
$1M · Seed | NPA, MedAdvisor | 1 to 10 | Pharma, Mobile, Ecommerce | B2C, Marketplace | London, UK | •••••••••••@charac.co.uk | |
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors. |
$6M · Seed | Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@myricxpharma.com | |
Lyphe group is a reliable supplier of medical cannabis care and medicine. |
$6M · Series A | Leafy Tunnel | 51 to 100 | Health Tech, Agritech, Pharma, Manufacturing, Cannabis | B2B | London, UK | •••••••••••@LYPHEGROUP.com | |
Immuno-oncology company treats cancer with antibodies. |
$2M · Series A | AlbionVC, Epidarex Capital, Novartis Venture Fund | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics | B2B | London, UK | •••••••••••@epsilogen.com | |
Immunotherapy for the treatment of cancer. |
$1M · Seed | UK Innovation & Science Seed Fund, Cancer Research Horizons | 11 to 50 | Biotech, Pharma | B2C | London, UK | •••••••••••@nk-io.com | |
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins. |
$2M | Hoxton Ventures, Bessemer Venture Partners | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | London, UK | •••••••••••@peptone.io | |
Short-duration psychedelic medicines developer for neuropsychiatric conditions. |
$40M · Series B | Leafy Tunnel, ATAI Life Sciences | 1 to 10 | Biotech, Pharma | B2C | Oxford, UK | •••••••••••@beckleypsytech.com | |
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening. |
$104k · Pre Seed | Atomico, Entrepreneur First | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics | B2B | London, UK | •••••••••••@exogene.co.uk | |
Tuli Health is a digital health platform that provides instant access to private medical appointments and testing. |
$125k · Pre Seed | Y Combinator | 1 to 10 | Health Tech, CPG & Consumer Goods, Pharma | B2B, SaaS | London, UK | •••••••••••@tuli.health | |
Developer of innovative treatment for muscle wasting disorders. |
$1M · Seed | Mankind Pharma | 1 to 10 | Biotech, Pharma | London, UK | •••••••••••@actimedtherapeutics.com | ||
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases. |
$56M · Series B | Balderton Capital, Atomico, Amadeus Capital | 51 to 100 | Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@healx.io | |
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. |
$275M | Wellington Management | 251 to 500 | Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics | B2B | Oxford, UK | •••••••••••@nanoporetech.com | |
Lab-quality diagnostics for anyone, anywhere, at any time. |
$85M | Oxford Science Enterprises | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Oxford, UK | •••••••••••@oslerdiagnostics.com | |
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases. |
$70M | Sofinnova Partners, Novo A/S, Forbion Capital Partners | 251 to 500 | Health Tech, Biotech, Pharma, Genetics | B2B | Manchester, UK | •••••••••••@f2g.com | |
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. |
N/A | Forbion Capital Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@pheontx.com | |
MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms. |
$29M | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Genetics | B2B | London, UK | •••••••••••@minatx.com | ||
Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated. |
N/A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things | B2B, SaaS | London, UK | •••••••••••@synthace.com | |
Pangaea Data provides a machine learning-based software solution making scientific and clinical data more meaningful. |
N/A | Ascension Ventures, Hambro Perks Ltd., IQ Capital Partners | 1 to 10 | Health Tech, AI, Machine Learning, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@pangaeadata.ai | |
Supply chain platfrom for pharma. |
$6M · Series A | 11 to 50 | Biotech, Pharma, Supply Chain & Logistics | London, UK | •••••••••••@veratrak.com | |||
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases |
$43M | Oxford Science Enterprises | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing, Genetics | B2B | Oxford, UK | •••••••••••@nucleome.com | |
Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company. |
$11M | Techstart Ventures | 1 to 10 | Health Tech, Pharma, Business Intelligence | Belfast, UK | •••••••••••@revanatx.com | ||
Epitopea is a transatlantic cancer immunotherapeutics company. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies. |
$6M · Series A | Oxford Science Enterprises | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Oxford, UK | •••••••••••@theolytics.com | |
CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies. |
$5M | Techstart Ventures | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Belfast, UK | •••••••••••@cv6t.com | |
Drug manufacturer. |
$10M · Series A | Biospring Partners | 501 to 1000 | Health Tech, Biotech, Pharma | B2B, SaaS | Cambridge, UK | •••••••••••@abzena.com | |
PetMedix is a pet therapeutics startup. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
PillSorted is a Pharmacy, blending compassionate care and innovative technology to deliver a truly Personal Pharmacy service. |
$6M · Seed | Hoxton Ventures | 11 to 50 | Health Tech, CPG & Consumer Goods, Pharma, Ecommerce | B2B, B2C, SaaS | Cambridge, UK | •••••••••••@pillsorted.com | |
Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers. |
$5M | Calculus Capital | 11 to 50 | Health Tech, Biotech, Pharma, Business Intelligence | B2B | Cambridge, UK | •••••••••••@axolbio.com | |
The free e-prescribing service chosen by Private GPs and Consultants to deliver medication to their patients nationwide |
$1M · Seed | 11 to 50 | Health Tech, Pharma, Ecommerce | B2B, B2C, Marketplace | London, UK | •••••••••••@pharmacierge.com | ||
Medino is the convenient online alternative to your High street Health and Wellness Shop. |
$574k · Seed | 1 to 10 | Health Tech, CPG & Consumer Goods, Pharma, Fitness, Mobile, Ecommerce | B2C | London, UK | •••••••••••@medino.com | ||
On a mission to power the pharmacy of the future, giving people the confidence to make the most of their medicines. |
$344k · Pre Seed | 1 to 10 | Health Tech, Hardware, Pharma, Mobile, Media and Entertainement, Ecommerce, ElderTech | B2C | London, UK | •••••••••••@weconnect.care | ||
A psychedelic-specialist clinical research organisation. |
$970k · Pre Seed | 1 to 10 | Health Tech, Biotech, Pharma, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@clerkenwellhealth.com | ||
Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies. |
$75M · Series C | 251 to 500 | Health Tech, Biotech, Pharma | B2B | Abingdon, UK | •••••••••••@immunocore.com | ||
Oxford Drug Design focuses on developing and delivering services and technologies in computer-aided drug discovery. |
$2M | ACF Investors | 1 to 10 | Health Tech, Biotech, Pharma, Food Delivery, Manufacturing | B2B, SaaS | Oxford, UK | •••••••••••@oxforddrugdesign.com | |
Patent-protected anti-inflammatory painkiller. |
N/A | 1 to 10 | Biotech, Pharma | London, UK | •••••••••••@ | |||
Solvotrin Therapeutics is a pharmaceutical company that focuses on improving and enhancing existing medications. |
$7M | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Cork, UK | •••••••••••@solvotrin.com | ||
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function. |
$18M | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Cambridge, UK | •••••••••••@nrgtherapeutics.com | ||
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery. |
$1M · Pre Seed | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@cardiatec.ai | ||
Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers. |
$150k · Pre Seed | Hoxton Ventures, Khosla Ventures, BACKED VC | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Oxford, UK | •••••••••••@ochre-bio.com | |
BrainWaveBank makes it possible to measure and track brain activity and cognitive performance for anyone, anytime, anywhere. |
$1M · Seed | Techstart Ventures | 11 to 50 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | B2B, SaaS | Belfast, UK | •••••••••••@brainwavebank.com | |
Biopharma |
$19M | 11 to 50 | Biotech, Pharma | Oxford, UK | •••••••••••@accessiontherapeutics.com | |||
Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement. |
$3M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@monocl.com | ||
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery. |
$2M · Seed | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Business Intelligence | B2B, SaaS | Cambridge, UK | •••••••••••@pharmenable.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.